Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review.

ABSTRACT:

Introduction

Buprenorphine-naloxone is recommended as a first-line agent for the treatment of opioid use disorder. Although initiation of buprenorphine in the emergency department (ED) is evidence based, barriers to implementation persist. A comprehensive review and critical analysis of both facilitators of and barriers to buprenorphine initiation in ED has yet to be published. Our objectives are (1) to map the implementation of buprenorphine induction pathway literature and synthesise what we know about buprenorphine pathways in EDs and (2) to identify gaps in this literature with respect to barriers and facilitators of implementation.

Methods and analysis

We will conduct a scoping review to comprehensively search the literature, map the evidence and identify gaps in knowle

SUBMITTER: Bozinoff N 

PROVIDER: S-EPMC8477333 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature